Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAGBiotechnology
+$2.32 today
- Market cap
- $1.83B
- Beta
- 0.00
Volume 0.30M
Average 0.34M
COAG Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Hemab Therapeutics Holdings, Inc. Common StockNASDAQ: COAG
Accumulated OCI · Q2 FY2026 · quarter ended Jun 2026
Accumulated OCI of $0 in Q2 FY2026
Q2 FY2026 Accumulated OCI was $0.
Context
- Accumulated OCI amounted to 0.0% of total assets at the end of Q2 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- 175K USD
- Year-over-year change
- —
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 175K | — |
Accumulated OCI vs competitors
How COAG compares with its peers on the latest reported figures
- COAG's Jun 2026 Accumulated OCI of $0 is the 3rd highest of the 5 companies compared; the peer median is -$1.38M.
- Accumulated OCI amounts to 0.0% of total assets for COAG, versus a peer median of 0.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
DMRADamora Therapeutics, Inc. | Mar 2026 | $754K | +151.3% | — | 0.1% |
| Mar 2026 | $1K | -97.9% | — | 0.0% | |
COAGHemab Therapeutics Holdings, Inc. Common Stock | Jun 2026 | $0 | — | — | 0.0% |
IRONDisc Medicine, Inc. | Sep 2026 | -$2.77M | -485.8% | — | 0.4% |
| Mar 2026 | -$59.89M | -11.3% | — | 7.7% | |
| Peer median (excluding COAG) | -$1.38M | -54.6% | — | 0.3% | |
Competitors are the stored peer set for COAG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG
Intrinsic Alpha fair value
Locked
Current Price
$39.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.